Specializing in life sciences and materials research, this company provides automated cold storage systems, sample management solutions, and genomic services. Its technology enables biopharma firms and academic institutions to streamline sample handling and data management. Investors monitor Azenta for its exposure to the growing biotech research tools market.
2 members of Congress have disclosed 9 trades in Azenta, Inc. (AZTA), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 5 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-03 | Gilbert Cisneros | buy | $1K – $15K |
| 2026-01-15 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-10-09 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-03-19 | Josh Gottheimer | sell | $1K – $15K |
| 2023-09-15 | Josh Gottheimer | sell | $1K – $15K |
| 2023-07-14 | Josh Gottheimer | buy | $1K – $15K |
| 2023-06-13 | Josh Gottheimer | sell | $1K – $15K |
| 2021-12-15 | Josh Gottheimer | sell | $1K – $15K |
| 2021-12-03 | Josh Gottheimer | sell | $1K – $15K |